New glasses aim to halt adult nearsightedness
NCT ID NCT06520124
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether Essilor Stellest spectacle lenses can slow the progression of nearsightedness (myopia) in adults aged 18 to 40. Each participant wears a Stellest lens in one eye and a standard lens in the other, allowing direct comparison. The trial measures changes in eye length and prescription over time, and also checks how comfortable adults find the lenses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Essilor Stellest spectacle lens (a lens with tiny lenslets designed to slow eye growth)
What this could lead to
If it works, this could give adults a non-surgical way to slow worsening nearsightedness, reducing future eye health risks.
What could go wrong
This is a small, early-stage trial with only 42 people. The lenses may not work as well in adults as in children, and some people may find them uncomfortable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA, PROGRESSIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ulster University
Coleraine, County Londonderry, BT52 1SA, United Kingdom